Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydroxyzine hydrochloride 10 mg oral tablet |
Is a |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 25 mg oral tablet |
Is a |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 10 mg/5 ml syrup |
Is a |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride [antihististamine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine HCl [anxiolytic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 50mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 500mg/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 10mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
ephedrinsulfat 6,25 mg + hydroxyzinhydrochlorid 2,5 mg + theophyllin 32,5 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
ephedrinsulfat + hydroxyzinhydrochlorid + theophyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 10 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 50 mg/1 ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 50 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 50 mg/1 ml injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 50 mg/1 ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
hydroxyzinhydrochlorid 50 mg/1 ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
|
Hydroxyzine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Hydroxyzine hydrochloride 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydroxyzine hydrochloride |
Inferred relationship |
Some |
1 |